MY ACCOUNT | NEWSLETTER |

Study: Novel intra-articular therapy effectively treats osteoarthritis in dogs


A new treatment is significantly more effective in improving symptoms of moderate to severe hip osteoarthritis in dogs than glucocorticoid alone, according to a study published in "Advances in Diagnostic and Treatment Methods for Joint Diseases in Dogs and Cats," a special issue published by the veterinary journal Animals.

Trial results show that one intra-articular shot of autologous conditioned serum (ACS) improves the overall health of dogs with osteoarthritis and that the combination of ACS with the glucocorticoid triamcinolone led to even faster and longer-lasting improvements in function and pain. 

Adult dogs with osteoarthritis in their hips suffer severe pain and limited movement, lowering their quality of life, according to a news release.

The study compared treatment with ACS alone, treatment with glucocorticoids alone and treatment with Orthogen AG's patented therapy of concomitant ACS and glucocorticoids.

ACS contains the entire blood cell secretome (BCS) after extended coagulation in a defined environment. It contains anti-inflammatory and anabolic proteins derived from the dog's own blood and is processed using Orthogen Veterinary's newly developed proprietary device.

Dr. Joao Alves, a veterinarian and the study's lead author, said in the news release that Orthogen's approach was a very effective treatment, with surprisingly sustainable results. Alves is a police captain who specializes in intra-articular treatments for osteoarthritis in highly trained police working dogs.

Dr. Julien Troillet, a veterinarian and managing director of Orthogen Veterinary GmbH, said the company is seeking global partners to make regenerative medicine broadly available to canine patients.

Learn more at: https://orthogen.com/irap/en/home-2/

Read the study at: https://www.mdpi.com/2076-2615/12/23/3358

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Pelvic limb anaesthesia and analgesia in dogs undergoing tibial plateau levelling osteotomy (TPLO): A survey of board-certified anesthesiologists

Like0
Dislike0

Treatment for refractory chronic gingivostomatitis in cats

Like0
Dislike0

What the Silicon Valley Bank collapse means for science start-ups

Like0
Dislike0

Zinpro’s 2022 Sustainability Report unveils plans to build a more sustainable world for all

Like0
Dislike0

Clinicopathological, radiographic indicators for orogastric decompression in rabbits with intestinal obstruction

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2023 - All Rights Reserved
ISSN 2768-198X

Top